15
Mar
2021
Software for the Cell & Gene Therapy Wave: Vineti’s Amy DuRoss on The Long Run
Today’s guest on The Long Run is Amy DuRoss. Amy is the co-founder and CEO of San Francisco-based Vineti. The company provides software to manage the delicate logistical dance for cell and gene therapies. Vineti has raised about $115 million in three venture rounds of financing. Its backers include Cardinal Health, the big medical distributor, as well as traditional venture... Read More